Cytosolic 5’-Nucleotidase II Interacts with the Leucin Rich Repeat of NLR Family Member Ipaf
暂无分享,去创建一个
C. Dumontet | A. Galli | L. Jordheim | R. Pesi | F. Cividini | M. Camici | S. Allegrini | M. Tozzi
[1] P. L. Ipata,et al. The functional logic of cytosolic 5'-nucleotidases. , 2013, Current medicinal chemistry.
[2] R. Pesi,et al. On the physiological role of cytosolic 5'-nucleotidase II (cN-II): pathological and therapeutical implications. , 2013, Current medicinal chemistry.
[3] Yongjin Park,et al. The Housekeeping Gene Hypoxanthine Guanine Phosphoribosyltransferase (HPRT) Regulates Multiple Developmental and Metabolic Pathways of Murine Embryonic Stem Cell Neuronal Differentiation , 2013, PloS one.
[4] F. Martinon,et al. Crystal Structure of NLRC4 Reveals Its Autoinhibition Mechanism , 2013, Science.
[5] Fabien Zoulim,et al. Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases , 2013, Nature Reviews Drug Discovery.
[6] A. Galli,et al. Expression of Bovine Cytosolic 5′-Nucleotidase (cN-II) in Yeast: Nucleotide Pools Disturbance and Its Consequences on Growth and Homologous Recombination , 2013, PloS one.
[7] W. Evans,et al. Relapse specific mutations in NT5C2 in childhood acute lymphoblastic leukemia , 2013, Nature Genetics.
[8] A. Ferrando,et al. Activating mutations in the NT5C2 nucleotidase gene drive chemotherapy resistance in relapsed ALL , 2013, Nature Medicine.
[9] E. Huizinga,et al. Formation and Structure of a NAIP5-NLRC4 Inflammasome Induced by Direct Interactions with Conserved N- and C-terminal Regions of Flagellin* , 2012, The Journal of Biological Chemistry.
[10] Theodore Friedmann,et al. Purinergic signaling in human pluripotent stem cells is regulated by the housekeeping gene encoding hypoxanthine guanine phosphoribosyltransferase , 2012, Proceedings of the National Academy of Sciences.
[11] Theodore Friedmann,et al. MicroRNA-mediated dysregulation of neural developmental genes in HPRT deficiency: clues for Lesch-Nyhan disease? , 2012, Human molecular genetics.
[12] Hao Xu,et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus , 2011, Nature.
[13] V. Radha,et al. NLRC4 (NLR Family, CARD domain containing 4) , 2011 .
[14] Theodore Friedmann,et al. HPRT Deficiency Coordinately Dysregulates Canonical Wnt and Presenilin-1 Signaling: A Neuro-Developmental Regulatory Role for a Housekeeping Gene? , 2011, PloS one.
[15] R. Pesi,et al. Active and regulatory sites of cytosolic 5′‐nucleotidase , 2010, The FEBS journal.
[16] A. Amer,et al. Nlrc4/Ipaf/CLAN/CARD12: more than a flagellin sensor. , 2010, The international journal of biochemistry & cell biology.
[17] V. Radha,et al. Interaction with Sug1 enables Ipaf ubiquitination leading to caspase 8 activation and cell death. , 2010, The Biochemical journal.
[18] R. Flavell,et al. The role of NOD-like Receptors in shaping adaptive immunity. , 2010, Current opinion in immunology.
[19] Richard Bonneau,et al. Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome , 2010, Proceedings of the National Academy of Sciences.
[20] C. Bryant,et al. Molecular mechanisms involved in inflammasome activation. , 2009, Trends in cell biology.
[21] M. Garcia-Gil,et al. Knockdown of cytosolic 5'-nucleotidase II (cN-II) reveals that its activity is essential for survival in astrocytoma cells. , 2008, Biochimica et biophysica acta.
[22] Gabriel Núñez,et al. Intracellular NOD-like receptors in host defense and disease. , 2007, Immunity.
[23] K. Murai,et al. Clinical significance of high-Km 5'-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome. , 2007, Leukemia research.
[24] C. Galmarini. What does over-expression of cN-II enzyme signify in haematological malignancies? , 2007, Leukemia research.
[25] Michael Karin,et al. Intracellular pattern recognition receptors in the host response , 2006, Nature.
[26] H. Spencer,et al. Enforced expression of cytosolic 5′-nucleotidase I confers resistance to nucleoside analogues in vitro but systemic chemotherapy toxicity precludes in vivo selection , 2006, Cancer Chemotherapy and Pharmacology.
[27] J. Mackey,et al. cN-II expression predicts survival in patients receiving gemcitabine for advanced non-small cell lung cancer. , 2005, Lung cancer.
[28] C. Galmarini,et al. Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells , 2005, Molecular Cancer Therapeutics.
[29] C. Dumontet,et al. Regulation and activity of cytosolic 5′‐nucleotidase II , 2005, FEBS letters.
[30] T. Kundu,et al. Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis , 2005, Oncogene.
[31] A. Scaloni,et al. Mechanistic studies on bovine cytosolic 5'-nucleotidase II, an enzyme belonging to the HAD superfamily. , 2004, European journal of biochemistry.
[32] Ruchi M. Newman,et al. Multiple Roles of CLAN (Caspase-Associated Recruitment Domain, Leucine-Rich Repeat, and NAIP CIIA HET-E, and TP1-Containing Protein) in the Mammalian Innate Immune Response1 , 2004, The Journal of Immunology.
[33] J. Mackey,et al. Deoxycytidine kinase and cN‐II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine , 2003, British journal of haematology.
[34] J. Ting,et al. Cutting Edge: CATERPILLER: A Large Family of Mammalian Genes Containing CARD, Pyrin, Nucleotide-Binding, and Leucine-Rich Repeat Domains1 , 2002, The Journal of Immunology.
[35] B. Mitchell,et al. ATP and phosphate reciprocally affect subunit association of human recombinant High Km 5'-nucleotidase. Role for the C-terminal polyglutamic acid tract in subunit association and catalytic activity. , 2001, European journal of biochemistry.
[36] A. Scaloni,et al. Bovine Cytosolic 5′-Nucleotidase Acts through the Formation of an Aspartate 52-Phosphoenzyme Intermediate* , 2001, The Journal of Biological Chemistry.
[37] S. Srinivasula,et al. Identification of Ipaf, a Human Caspase-1-activating Protein Related to Apaf-1* , 2001, The Journal of Biological Chemistry.
[38] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[39] V. Micheli,et al. Cytosolic 5′‐nucleotidase hyperactivity in erythrocytes of Lesch–Nyhan syndrome patients , 2000, Neuroreport.
[40] P. Reichard,et al. Induction of human high K(M) 5'-nucleotidase in cultured 293 cells. , 1999, Experimental cell research.
[41] P. Reichard,et al. Human high-Km 5'-nucleotidase effects of overexpression of the cloned cDNA in cultured human cells. , 1999, European journal of biochemistry.
[42] R. Pesi,et al. Bovine cytosolic IMP/GMP-specific 5'-nucleotidase: cloning and expression of active enzyme in Escherichia coli. , 1997, The Biochemical journal.
[43] C. Baiocchi,et al. The phosphotransferase activity of cytosolic 5'-nucleotidase; a purine analog phosphorylating enzyme. , 1996, The international journal of biochemistry & cell biology.
[44] M. Turriani,et al. The bifunctional cytosolic 5'-nucleotidase: regulation of the phosphotransferase and nucleotidase activities. , 1994, Archives of biochemistry and biophysics.
[45] T. Kipps,et al. Relationship of deoxycytidine kinase and cytoplasmic 5'-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine. , 1993, Blood.
[46] F. Sgarrella,et al. Nucleoside phosphotransferase activity of human colon carcinoma cytosolic 5'-nucleotidase. , 1991, Archives of biochemistry and biophysics.
[47] V. Madrid-Marina,et al. High Km soluble 5'-nucleotidase from human placenta. Properties and allosteric regulation by IMP and ATP. , 1988, The Journal of biological chemistry.
[48] R Itoh,et al. Purification and some properties of cytosol 5'-nucleotidase from rat liver. , 1981, Biochimica et biophysica acta.
[49] F. Sutterwala,et al. NLRC4/IPAF: a CARD carrying member of the NLR family. , 2009, Clinical immunology.
[50] R. Schiestl,et al. High-efficiency yeast transformation using the LiAc/SS carrier DNA/PEG method , 2007, Nature Protocols.